Next Pharmaceuticals, Carlsbad, CA, has signed an exclusive supply agreement with Kelatron, Ogden, UT, for access to its patented Chromulin (U.S. Patent No. 6,689,383) product, which is a water-soluble, bioavailable form of chromium that is ideal for beverage applications and foods targeting any aspect of carbohydrate, protein and fat metabolism. Chromulin features a natural combination of the essential mineral chromium III and the essential amino acid histidine, which was formulated and patented by Dr. Richard Anderson at the USDA.